---
schema_version: "secwatch.filing_event.v1"
accession: "0001156039-26-000006"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2026-01-28T23:59:59+00:00"
generated_at: "2026-05-16T06:53:47.745837+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Elevance Health Q4 adj. EPS $3.33 on higher medical costs; FY2026 adj. EPS guide $25.50, down from $30.29

## Summary
- Q4 2025 GAAP diluted EPS $2.47; adjusted $3.33; operating revenue $49.3B (+10% YoY).
- Full year 2025 GAAP EPS $25.21; adjusted $30.29; operating revenue $197.6B (+13% YoY).
- Health Benefits segment Q4 adjusted operating loss of $0.2B; benefit expense ratio 93.5% (+110 bps YoY).
- FY2026 guidance: GAAP EPS at least $22.30; adjusted EPS at least $25.50; targeting 12% adjusted EPS growth in 2027.
- Returned $4.1B to shareholders in 2025; quarterly dividend raised to $1.72 per share.

## SEC filing metadata
- accession: 0001156039-26-000006
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2026-01-28T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000115603926000006/0001156039-26-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000115603926000006/elv-20260128.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001156039-26-000006
- JSON: https://secwatch.observer/filing/0001156039-26-000006.json
- Plain text: https://secwatch.observer/filing/0001156039-26-000006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.